Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Taq DNA polymerase market competitive
12-28-2005
SHARING OPTIONS:

Since March 28, 2005, life science researchers no longer need a license to practice the basic PCR amplification process, which was covered by a number of patents. The result of these patent expirations is an opportunity for many life science companies to become suppliers of Taq DNA polymerase to scientists for PCR amplification. Once Taq DNA polymerase has been incorporated into a scientists tool box, it likely remains there for many years. This according to a recent report entitled "Taq Wars: Competitive Intelligence on How to Survive" from research firm BioInformatics LLC
 
Based on a 28-question survey of researchers who use Taq DNA polymerase, this reports examines the buying decisions of researchers and how their decisions are influenced by their market segment. The report also provides a detailed report of price sensitivity among buyers, as well as the relationship between price and performance which can provide insights on how Taq DNA polymerase suppliers can retain their current cusomters base and attract new customers.
 
Some key findings of the report :
  • More academic scientists than industrial or governmental scientists prefer to use RNA or cDNA templates over DNA templates for real-time quantitative PCR.
  • Two-fifths of respondents say that the amount of Taq polymerase they use will increase over the next 12 months.
  • Two-fifths of all respondents have been using their primary brand of Taq polymerase for three to four years.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.